SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-025066
Filing Date
2022-11-14
Accepted
2022-11-14 17:20:42
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lhdx-20221114.htm   iXBRL 8-K 57776
2 EX-99.1 lhdx-ex99_1.htm EX-99.1 623433
3 GRAPHIC img195784789_0.jpg GRAPHIC 5192
  Complete submission text file 0000950170-22-025066.txt   832646

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lhdx-20221114_lab.xml EX-101.LAB 14018
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lhdx-20221114_pre.xml EX-101.PRE 10295
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lhdx-20221114.xsd EX-101.SCH 2481
8 EXTRACTED XBRL INSTANCE DOCUMENT lhdx-20221114_htm.xml XML 4926
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39976 | Film No.: 221387782
SIC: 2835 In Vitro & In Vivo Diagnostic Substances